BOOM Q1 2026 Earnings Surprising EPS Beat Despite Challenging Environment Sonoma Pharmaceuticals Inc SNOA Q1 2026 Earnings EPS Slightly Misses Estimates Amid Thin Revenue Disclosures IMOS Q1 2026 Earnings EPS Misses Estimates Stock Gains Amid Industry Uncertainty Protara Therapeutics TARA Q1 2026 Earnings Narrower Loss Beats Street Estimates on Cost Management Nutex Health Inc NUTX Q1 2026 Earnings EPS Surges Past Estimates MGRD Q1 2026 Earnings Asset Manager Posts Slight EPS Beat Amid Steady Operations